The Crucial Role of Health Economics and Outcomes Research in Biopharma’s Future

In a recent analysis, experts emphasize the pivotal role that Health Economics and Outcomes Research (HEOR) plays in the biopharmaceutical sector. As regulatory and payer demands for comprehensive evidence increase, HEOR is becoming an essential element for companies striving to maintain a competitive edge.

The report highlights that enhancing the visibility and understanding of HEOR within corporate C-suites is crucial. It argues that neglecting investment in HEOR could disadvantage companies as they navigate the complex landscape of healthcare regulations and expectations.

Date: February 28, 2025.

Newsflash | Powered by GeneOnline AI

Author

Mark Chiang

Related Post

US BIO 2025

Psychedelics Are Driving a Mental Health Revolution with Long-Lasting Therapeutic Potential

2025-06-17